Literature DB >> 941834

Differing mechanisms for ventricular vulnerability during coronary artery occlusion and release.

R Corbalan, R L Verrier, B Lown.   

Abstract

The time course and mechanism of vulnerability to ventricular fibrillation (VF) a 10-minute occlusion of the left anterior descending coronary artery and following its release were studied in 48 dogs. VF threshold was determined by inducing a sequence of three extrasystoles (sequential R/T pulsing). Within 1 minute of occlusion, the fibrillation current decreased to the level required for eliciting a propagated diastolic response. This state of enhanced vulnerability lasted for approximately 6 minutes, after which the VF threshold returned to preocclusion values. The vulnerability changes upon reperfusion, by comparison, occurred within seconds of release and persisted only transiently. Three minutes of occlusion was the minimal time which resulted in a reduction in VF threshold after release. Alpha and beta-adrenergic blockade with phentolamine and propranolol, respectively, prevented the decrease in VF threshold during occlusion but were without effect upon threshold changes during coronary artery release. Lidocaine failed to alter the pattern of vulnerability. It is concluded that adrenergic mechanisms play a key role in the increased susceptibility to VF associated with acute myocardial ischemia, whereas the changes in VF threshold following reperfusion may be due to washout products of cellular ischemia. These findings support the view that protection against VF during coronary artery occlusion and release may require different antiarrhythmic measures.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 941834     DOI: 10.1016/s0002-8703(76)80258-x

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  18 in total

1.  Reperfusion Injury: Does It Exist and Does It Have Clinical Relevance?

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997-01       Impact factor: 2.300

Review 2.  Reperfusion-induced injury: a possible role for oxidant stress and its manipulation.

Authors:  D J Hearse
Journal:  Cardiovasc Drugs Ther       Date:  1991-03       Impact factor: 3.727

3.  The role of cyclic adenosine monophosphate in adrenergic effects on ventricular vulnerability to fibrillation in the isolated perfused rat heart.

Authors:  W F Lubbe; T Podzuweit; P S Daries; L H Opie
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

4.  Cardioprotective and antiarrhythmic effects of beta-blockers, propranolol, bisoprolol, and nipradilol in a canine model of regional ischemia.

Authors:  T Ogawa; N Hieda; S Sugiyama; T Ito; T Satake; T Ozawa
Journal:  Heart Vessels       Date:  1989       Impact factor: 2.037

5.  Experimental studies of electroacupuncture on ventricular fibrillation threshold in rats with acute ischemic myocardium.

Authors:  Z Liu; Y Chen; B Shi; X Ouyang; X Guan
Journal:  J Tongji Med Univ       Date:  1998

6.  Antiarrhythmic effects of a benzothiazine derivative (SD-3211) and its stereoisomer (SA3212) in anaesthetized rats and isolated perfused rat hearts compared with bepridil.

Authors:  M Fukuchi; T Uematsu; S Nagashima; M Nakashima
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-06       Impact factor: 3.000

7.  The ionic mechanism of reperfusion-induced early afterdepolarizations in feline left ventricular hypertrophy.

Authors:  T Furukawa; A L Bassett; N Furukawa; S Kimura; R J Myerburg
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

8.  The interaction of calcium and cAMP and the relationship to ventricular vulnerability.

Authors:  F T Thandroyen; L M Higginson; L H Opie
Journal:  Basic Res Cardiol       Date:  1981 Jul-Aug       Impact factor: 17.165

Review 9.  Ischemia, reperfusion, and the determinants of tissue injury.

Authors:  D J Hearse
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

10.  Changes in ventricular fibrillation threshold during repeated short-term coronary occlusion and release.

Authors:  H Gülker; B Krämer; K Stephan; W Meesmann
Journal:  Basic Res Cardiol       Date:  1977 Sep-Oct       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.